Syneos Health announced the appointment of Costa Panagos as CEO, effective immediately. Panagos succeeds Colin Shannon who has been appointed Executive Chairman. Panagos is a widely respected leader with more than 25 years of experience managing and driving growth at contract research organizations (CRO), with a proven track record of operational excellence and attracting and retaining customers.
He most recently served as President, Research & Development Solutions at IQVIA, where he led the expansion of its network and capabilities and achieved record service bookings. Panagos joined IQVIA in 1999 as part of the Quintiles organization and during his more than two decades at the company, he held numerous sales, operational and executive leadership roles, including serving as the CEO of Second Quarter Solutions. Earlier in his career, he held various roles in the pharmaceutical division of Bayer.
